✦ LIBER ✦

510 Pharmacokinetics (PK) and effects on irinotecan (CPT-11) disposition of selenium (Se) during a phase I study of CPT-11 in combination with selenomethionine (SLM) in patients with advanced solid tumors

✍ Scribed by L. Pendyala; P. Smith; M. Fakih; P. Creaven; J. Prey; M. Murphy; Y. Rustum

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of weekly CPT-11 (irinotec

✍ Font, A; Sanchez, J.M; Rosell, R; Taron, M; Martinez, E; Guillot, M; Manzano, J. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Phase I and pharmacoklnetic (PK) study o

✍ de Jonge, M.J.A.; Spareboom, A.; Planting, A.S.Th.; van der Burg, M.E.L; de Brui 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Phase I and pharmacokinetic study (PK) o

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 277 KB

A phase I study of combination therapy w

✍ Manabu Shiozawa; Nobuhiro Sugano; Kazuhito Tsuchida; Soichiro Morinaga; Makoto A 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

A phase I study and pharmacokinetics of

✍ Hotta, Katsuyuki; Ueoka, Hiroshi; Kiura, Katsuyuki; Tabata, Masahiro; Kuyama, Sh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 103 KB

A phase I study of irinotecan (CPT-11) a

✍ Kakolyris, S; Kouroussis, Ch; Mavroudis, D; Souglakos, J; Kalbakis, K; Agelaki, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB